ADGRG2 (Gene)

Synonyms:ADGRG2, CBAVDX, EDDM6, ENTREZ:10149, GPR64, HE6, HGNC:4516, MIM:300572, NM_001079858, NM_001079859, NM_001079860, NM_001184833, NM_001184834, NM_001184835, NM_001184836, NM_001184837, NM_005756, NP_001073327, NP_001073328, NP_001073329, NP_001171762, NP_001171763, NP_001171764, NP_001171765, NP_001171766, NP_005747, TM7LN2, XM_006724455, XM_011545434, XM_011545435, XP_006724518, XP_011543736, XP_011543737, adhesion G protein-coupled receptor G2
Omim:OMIM:300572
Id:ENSG00000173698
Hgnc:HGNC:4516
Entrez:10149
Description:adhesion G protein-coupled receptor G2
This gene encodes a member of the G protein-coupled receptor family described as an epididymis-specific transmembrane protein. The encoded protein may be proteolytically processed as it contains a motif shown to be a protein scission motif in some members of this family (PMID: 11973329). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ADGRG2's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ADGRG2.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ADGRG2.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ADGRG2.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ADGRG2.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.